Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ramipril + Amlodipine + Hct

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 82090183

  Document Type - Tender Notices

Description - Description: Section 130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. GWQ acts as a company for efficiency and quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBV for its shareholders and customer funds. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until new drug discount agreements come into force, GWQ would like to con

Mt Ref Id - 82090183

Deadline - Nov 10, 2025